




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>SCD/Ventricular Arrhythmias</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=cef7f268-5201-449f-829a-cd37615b5acf</link>
        <description>Clinical Topic Feed: SCD/Ventricular Arrhythmias</description>
        <language>en</language>

        

                <item>
                    <title>Eagle&#226;€™s Eye View: Imaging Identifies HCM Patients at High-Risk of Adverse Outcomes </title>
<link>/Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment.</description>
                    <pubdate>1779288780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Did Disparities in ICD Implantations Worsen During the COVID-19 Pandemic? | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/15/14/32/Did-Disparities-in-ICD-Implantations-Worsen</link>                    <description>The incidence of ICD implantations declined significantly during the COVID-19 pandemic, according to a recent study published in Heart Rhythm. Although disparities by sex, race and ethnicity persisted during peak COVID, they did not worsen.</description>
                    <pubdate>1778884980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AFib Ablation Approaches Differ by Hospital Teaching Status | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/15/14/32/AFib-Ablation-Approaches-Differ-by-Hospital-Teaching-Status</link>                    <description>Procedural approaches for atrial fibrillation (AFib) ablation differ by hospital teaching status; however, overall complication rates are similar, according to a recent study published in JAHA.</description>
                    <pubdate>1778884980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Ivabradine vs. Propranolol For POTS; Testosterone Prescribing Trends</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/Ivabradine-vs-Propranolol</link>                    <description>Both ivabradine and propranolol reduced tachycardia and symptoms of postural orthostatic tachycardia syndrome (POTS), compared with placebo, based on findings from a randomized, double-blind crossover trial published in JACC and JACC: Advances.</description>
                    <pubdate>1778688060000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>&#226;€&#175;Eagle&#226;€™s Eye View: Can Rhythm Control Improve Tricuspid Regurgitation? </title>
<link>/Latest-in-Cardiology/Articles/2026/05/12/15/21/eagles-eye-view-13may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle examines the role of rhythm control in improving moderate-to-severe and severe secondary tricuspid valve regurgitation.</description>
                    <pubdate>1778679000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New in Clinical Guidance | Key Points From the 2026 Advanced Training Statement on CCEP</title>
<link>/Latest-in-Cardiology/Articles/2026/06/01/01/New-in-Clinical-Guidance-2026-ATS-CCEP</link>                    <description>The following are key points from the 2026 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (Revision of the 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology)...</description>
                    <pubdate>1778156160000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CARES Data: Odds of Positive OHCA Outcomes Worsen at Night</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/CARES-Data</link>                    <description>Nighttime response for out-of-hospital cardiac arrest (OHCA) was associated with lower odds of sustained return of spontaneous circulation (ROSC), neurologically favorable survival (Cerebral Performance Category of 1 or 2) and postresuscitation survival compared to daytime, even after adjusting for patient and event characteristics...</description>
                    <pubdate>1778087340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>&#226;€&#175;Eagle&#226;€™s Eye View: PCI Vs. CABG In Patients With Unprotected Left Main CAD: NOBLE Study </title>
<link>/Latest-in-Cardiology/Articles/2026/05/06/13/43/eagles-eye-view-06may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at the NOBLE trial evaluating whether percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is best for patients with unprotected left main coronary artery disease (CAD).</description>
                    <pubdate>1778075040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AVANT-GUARD: Pulsed Field Ablation as First-Line Therapy For Patients With Persistent AFib</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/AVANT-GUARD</link>                    <description>The likelihood of recurrence of atrial arrhythmia in patients with persistent atrial fibrillation (AFib) was lower for those who received pulsed field ablation (PFA) as first-line therapy when compared to those who first tried antiarrhythmic drug (AAD) therapy, according to results from the AVANT-GUARD trial published April 25 in NEJM.</description>
                    <pubdate>1777994460000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CLEAR-VT Registry: Catheter Ablation of Ventricular Arrhythmias With a Dual-Energy Lattice-Tip Catheter</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/04/27/14/03/CLEAR-VT-Registry</link>                    <description>Catheter ablation of ventricular arrhythmias (VAs) with a lattice-tip catheter that allows toggling between radiofrequency ablation and pulsed field ablation (PFA) &quot;appeared effective and generally safe,&quot; based on findings from the CLEAR-VT Registry late-breaking clinical trial presented at HRS 2026...</description>
                    <pubdate>1777298640000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>